NEUPERT PETER M

SEC Form 4 insider
Adaptive Biotechnologies Corp ($ADPT)
1 thesis · first seen Aug 20, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d
3d
1w
1m
3m
6m
1y

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$ADPTSEC Form 4bearish
Sold 124,690 @ $25.15 avg · $3,135,850 · 2026-08-17

Form 4: NEUPERT PETER M sold ADPT

NEUPERT PETER M (Director at Adaptive Biotechnologies Corp) reported an open-market sale of 124,690 shares of ADPT at an average $25.15, roughly $3,135,850, in a Form 4 filed 2026-08-19.

View filing on SEC.gov →

End of results.